Huadong Medicine Co Ltd (000963) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Huadong Medicine Co Ltd (000963) has a cash flow conversion efficiency ratio of 0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥155.98 Million ≈ $22.82 Million USD) by net assets (CN¥24.50 Billion ≈ $3.58 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Huadong Medicine Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)
This chart illustrates how Huadong Medicine Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 000963 total liabilities for a breakdown of total debt and financial obligations.
Huadong Medicine Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Huadong Medicine Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
New Oriental Education & Technology
NYSE:EDU
|
0.123x |
|
ALD SA
PA:AYV
|
1.195x |
|
Norwegian Cruise Line Holdings Ltd
NYSE:NCLH
|
0.208x |
|
AKZO NOBEL SPONS.ADRS 1/3
F:AKUP
|
0.096x |
|
Moog Inc
NYSE:MOG-A
|
-0.022x |
|
Albertsons Companies
NYSE:ACI
|
0.659x |
|
Zhejiang Huafon Spandex Co Ltd
SHE:002064
|
0.059x |
|
Ryder System Inc
NYSE:R
|
-0.614x |
Annual Cash Flow Conversion Efficiency for Huadong Medicine Co Ltd (1998–2024)
The table below shows the annual cash flow conversion efficiency of Huadong Medicine Co Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see Huadong Medicine Co Ltd (000963) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥23.56 Billion ≈ $3.45 Billion |
CN¥3.75 Billion ≈ $548.59 Million |
0.159x | -12.61% |
| 2023-12-31 | CN¥21.58 Billion ≈ $3.16 Billion |
CN¥3.93 Billion ≈ $574.97 Million |
0.182x | +46.58% |
| 2022-12-31 | CN¥19.18 Billion ≈ $2.81 Billion |
CN¥2.38 Billion ≈ $348.54 Million |
0.124x | -33.62% |
| 2021-12-31 | CN¥16.94 Billion ≈ $2.48 Billion |
CN¥3.17 Billion ≈ $463.84 Million |
0.187x | -16.75% |
| 2020-12-31 | CN¥15.18 Billion ≈ $2.22 Billion |
CN¥3.41 Billion ≈ $499.20 Million |
0.225x | +44.46% |
| 2019-12-31 | CN¥12.87 Billion ≈ $1.88 Billion |
CN¥2.00 Billion ≈ $292.91 Million |
0.156x | -20.47% |
| 2018-12-31 | CN¥10.43 Billion ≈ $1.53 Billion |
CN¥2.04 Billion ≈ $298.44 Million |
0.196x | +3.74% |
| 2017-12-31 | CN¥8.81 Billion ≈ $1.29 Billion |
CN¥1.66 Billion ≈ $243.07 Million |
0.189x | +6.99% |
| 2016-12-31 | CN¥7.64 Billion ≈ $1.12 Billion |
CN¥1.35 Billion ≈ $197.10 Million |
0.176x | -13.19% |
| 2015-12-31 | CN¥3.24 Billion ≈ $474.60 Million |
CN¥658.54 Million ≈ $96.36 Million |
0.203x | -30.97% |
| 2014-12-31 | CN¥2.52 Billion ≈ $368.56 Million |
CN¥740.85 Million ≈ $108.41 Million |
0.294x | +85.94% |
| 2013-12-31 | CN¥3.02 Billion ≈ $441.21 Million |
CN¥476.98 Million ≈ $69.80 Million |
0.158x | -42.36% |
| 2012-12-31 | CN¥2.34 Billion ≈ $342.72 Million |
CN¥642.73 Million ≈ $94.05 Million |
0.274x | +2954.34% |
| 2011-12-31 | CN¥1.79 Billion ≈ $262.60 Million |
CN¥16.12 Million ≈ $2.36 Million |
0.009x | +143.20% |
| 2010-12-31 | CN¥1.35 Billion ≈ $196.94 Million |
CN¥-27.99 Million ≈ $-4.10 Million |
-0.021x | -104.74% |
| 2009-12-31 | CN¥1.29 Billion ≈ $189.31 Million |
CN¥567.94 Million ≈ $83.11 Million |
0.439x | +13.71% |
| 2008-12-31 | CN¥892.80 Million ≈ $130.64 Million |
CN¥344.69 Million ≈ $50.44 Million |
0.386x | -0.61% |
| 2007-12-31 | CN¥684.27 Million ≈ $100.13 Million |
CN¥265.79 Million ≈ $38.89 Million |
0.388x | +393.01% |
| 2006-12-31 | CN¥728.30 Million ≈ $106.57 Million |
CN¥57.38 Million ≈ $8.40 Million |
0.079x | -73.38% |
| 2005-12-31 | CN¥686.99 Million ≈ $100.53 Million |
CN¥203.33 Million ≈ $29.75 Million |
0.296x | +1435.72% |
| 2004-12-31 | CN¥648.91 Million ≈ $94.96 Million |
CN¥12.51 Million ≈ $1.83 Million |
0.019x | -86.42% |
| 2003-12-31 | CN¥637.95 Million ≈ $93.35 Million |
CN¥90.54 Million ≈ $13.25 Million |
0.142x | +260.25% |
| 2002-12-31 | CN¥607.81 Million ≈ $88.94 Million |
CN¥23.94 Million ≈ $3.50 Million |
0.039x | -79.24% |
| 2001-12-31 | CN¥578.05 Million ≈ $84.59 Million |
CN¥109.67 Million ≈ $16.05 Million |
0.190x | +400.09% |
| 2000-12-31 | CN¥516.34 Million ≈ $75.56 Million |
CN¥19.59 Million ≈ $2.87 Million |
0.038x | -66.12% |
| 1999-12-31 | CN¥502.91 Million ≈ $73.59 Million |
CN¥56.32 Million ≈ $8.24 Million |
0.112x | +5.70% |
| 1998-12-31 | CN¥224.63 Million ≈ $32.87 Million |
CN¥23.80 Million ≈ $3.48 Million |
0.106x | -- |
About Huadong Medicine Co Ltd
Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. It operates through Pharmaceutical Industry, Pharmaceutical Business, Aesthetic Medicine, and Industrial Microbiology segments. The company distributes Chinese and western medicines, Chinese herbal medicines, and medical instruments; and immunosup… Read more